leucyl-tRNA synthetase inhibitors (Omnia Molecular)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameleucyl-tRNA synthetase inhibitors (Omnia Molecular)
Drug Alias NameSysteMTbaminoacyl-tRNA synthetase inhibitors (Omnia Molecular)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeucyl-tRNA synthetase inhibitors
TargetsLeucyl-tRNA synthetase
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOmnia Molecular
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOmnia Molecular
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A